SCHEMBL987144

SCHEMBL987144

Cc1c(F)cc(C(=O)Cl)cc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.57
HDAC6 Q9UBN7 3/20 0.57
CES2 O00748 4/20 0.41
CES1 P23141 4/20 0.41
ALDH1A1 P00352 5/20 0.37
ALOX15 P16050 1/20 0.37
LMNA P02545 4/20 0.34
HTT P42858 3/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
KCNQ3 O43525 2/20 0.34
KCNQ2 O43526 2/20 0.34
KCNE1 P15382 2/20 0.34
KCNQ1 P51787 2/20 0.34
KMT2A Q03164 2/20 0.33
KCNQ5 Q9NR82 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26626630 0.86 HDAC1 (0.48) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL30601660 0.86 HDAC1 (0.48) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL4495302 0.86 HDAC1 (0.44) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL12377615 0.80 CES2 (0.46) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL193908 0.80 CES2 (0.64) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL30601730 0.80 MEN1 (0.45) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL26626614 0.80 MEN1 (0.45) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL7922005 0.78 CES2 (0.42) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL1105952 0.78 HDAC1 (0.59) HDAC1HDAC6CES2CES1ALDH1A1
SCHEMBL13125486 0.78 HDAC1 (0.59) HDAC1HDAC6CES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875631-B2 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed ANALYTECON S.A. (CH) 2011-01-25 US disclosed
US-5117057-A Insecticidal N' substituted-N-N'-disubstituted-hydrazines ROHM AND HAAS COMPANY (US) 1992-05-26 US disclosed
US-4762844-A ANIMAL GROWTH REGULATORS BAYER AKTIENGESELLSCHAFT (DE) 1988-08-09 US disclosed
EP-0181588-A2 Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids, process for their preparation, and antibacterial agents containing them BAYER AG (DE) 1986-05-21 EP disclosed